Filing Details

Accession Number:
0000899243-21-036773
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-21 16:15:08
Reporting Period:
2021-09-17
Accepted Time:
2021-09-21 16:15:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590877 Regenxbio Inc. RGNX Biological Products, (No Disgnostic Substances) (2836) 471851754
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652936 M. Allan Fox C/O Regenxbio Inc.
9804 Medical Center Drive
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-17 48,233 $45.04 1,364,309 No 4 S Indirect By DING LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By DING LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 315,000 Indirect By HBF Gift Trust LLC
Common Stock 278,541 Indirect By Fox 2020 Trust
Common Stock 315,000 Indirect By AMF Gift Trust LLC
Common Stock 722,485 Indirect By AMF Family Gift Trust LLC
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $45.00 to $45.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.